| Literature DB >> 24824477 |
Brandon W Heimer1, Tatyana A Shatova, Jungkyu K Lee, Kaja Kaastrup, Hadley D Sikes.
Abstract
Hypermethylation of CpG islands in gene promoter regions has been shown to be a predictive biomarker for certain diseases. Most current methods for methylation profiling are not well-suited for clinical analysis. Here, we report the development of an inexpensive device and an epigenotyping assay with a format conducive to multiplexed analysis.Entities:
Mesh:
Substances:
Year: 2014 PMID: 24824477 PMCID: PMC4312478 DOI: 10.1039/c4an00667d
Source DB: PubMed Journal: Analyst ISSN: 0003-2654 Impact factor: 4.616